BioSpace News Archive

Today, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital therapeutic device to improve attention function in children with attention deficit hyperactivity disorder (ADHD)

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America Securities 2020 Napa Biopharma Conference at 2:00 p.m. PT (5:00 p.m. ET) on Monday, June 22, 2020. Kevin Gorman, Chief Executive Officer, will present at the conference.

The Patient Safety Authority has released its 2019 annual report, offering key insights to inspire change and improve patient safety in Pennsylvania and beyond.

Guardion Health Sciences, Inc. announced that its Board of Directors has appointed Dr. David Evans, Ph.D. as the Company’s Interim President and Interim Chief Executive Officer effective immediately.

Iterum Therapeutics plc, a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, announced results of its Annual General Meeting held on June 10, 2020.

Zentalis Pharmaceuticals, Inc. announced that Ahmed Samatar, Ph.D., Senior Vice President of Oncology Research at Zentalis, will present preclinical data on ZN-c5 at the upcoming American Association of Cancer Research Virtual Annual Meeting II taking place June 22-24th.

Latest CDC and NIDDK sponsored SEARCH for Diabetes in Youth research indicates substantial percentage of today’s youth with diabetes are not meeting recommended A1C goals

Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, announced the launch of the iPLEX® Pro SARS-CoV-2 Panel for qualitative detection of the novel coronavirus that causes COVID-19.

Ovation Science Inc. (“Ovation” or the “Company”) is pleased to announce it has signed a revised agreement for additional rights for its DermSafe hand sanitizer (the “License Renewal Agreement”) under the terms of the original License Agreement with Skinvisible Pharmaceuticals, Inc., previously announced February 13, 2020.

Preferred Commerce, Inc. (OTC PINK:OCBM) announced today that full-scale distribution has launched on its new line of cutting edge supplements, THRIV5, bringing to market the most highly advanced all-natural immune system support and nutritional enhancement products ever recorded